Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberto Pili

Showing results (71-80 of 223) with videos related to

Pageof 23
Sort By:
Journal of Public Health Research|June 19, 2024
Digital determinants of health as a way to address multilevel complex causal model in the promotion of Digital health equity and the prevention of digital health inequities: A scoping reviewDonatella Rita Petretto, Gian Pietro Carrogu, Luca Gaviano, et al.
Journal of Cancer Research and Clinical Oncology|August 4, 2023
Characteristics and predictors associated with cancer-related fatigue among solid and liquid tumorsPoolakkad S Satheeshkumar, Roberto Pili, Joel B Epstein, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 4, 2026
Measurement of patients' acceptable symptom levels and priorities for symptom improvement in advanced prostate cancerStella Snyder, Ekin Secinti, Ellen F Krueger, et al.
Cancer Medicine|March 27, 2025
A Phase I/IB, Open Label, Dose Finding Study to Evaluate Safety, Pharmacodynamics and Efficacy of Pembrolizumab in Combination With Vorinostat in Patients With Advanced Prostate, Renal or Urothelial CarcinomaRoberto Pili, David I Quinn, Nabil Adra, et al.
European Journal of Cancer (Oxford, England : 1990)|October 25, 2011
The association of pre-treatment neutrophil to lymphocyte ratio with response rate, progression free survival and overall survival of patients treated with sunitinib for metastatic renal cell carcinomaDaniel Keizman, Maya Ish-Shalom, Peng Huang, et al.
Journal of Public Health Research|September 21, 2021
COVID-19 and the excess of mortality in Italy from January to April 2020: what are the risks for oldest old?Eraldo Francesco Nicotra, Roberto Pili, Luca Gaviano, et al.
Geriatrics (Basel, Switzerland)|September 23, 2024
Reconsidering "Aging Well" According to Multiple Definitions: A Multidimensional Approach to Clinical Psychology of AgingLuca Gaviano, Roberto Pili, Andrea Domenico Petretto, et al.
Geriatrics (Basel, Switzerland)|September 23, 2024
Definitions of Ageing According to the Perspective of the Psychology of Ageing: A Scoping ReviewLuca Gaviano, Roberto Pili, Andrea Domenico Petretto, et al.
Journal of Medicinal Chemistry|April 28, 2006
Identification of type 1 inosine monophosphate dehydrogenase as an antiangiogenic drug targetCurtis R Chong, David Z Qian, Fan Pan, et al.
Cancer Research|September 18, 2004
The histone deacetylase inhibitor NVP-LAQ824 inhibits angiogenesis and has a greater antitumor effect in combination with the vascular endothelial growth factor receptor tyrosine kinase inhibitor PTK787/ZK222584David Z Qian, Xiaofei Wang, Sushant K Kachhap, et al.
Pageof 23

Showing results (71-80 of 223) with videos related to

Sort By:
Pageof 23
Journal of Public Health Research|June 19, 2024
Digital determinants of health as a way to address multilevel complex causal model in the promotion of Digital health equity and the prevention of digital health inequities: A scoping reviewDonatella Rita Petretto, Gian Pietro Carrogu, Luca Gaviano, et al.
Journal of Cancer Research and Clinical Oncology|August 4, 2023
Characteristics and predictors associated with cancer-related fatigue among solid and liquid tumorsPoolakkad S Satheeshkumar, Roberto Pili, Joel B Epstein, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 4, 2026
Measurement of patients' acceptable symptom levels and priorities for symptom improvement in advanced prostate cancerStella Snyder, Ekin Secinti, Ellen F Krueger, et al.
Cancer Medicine|March 27, 2025
A Phase I/IB, Open Label, Dose Finding Study to Evaluate Safety, Pharmacodynamics and Efficacy of Pembrolizumab in Combination With Vorinostat in Patients With Advanced Prostate, Renal or Urothelial CarcinomaRoberto Pili, David I Quinn, Nabil Adra, et al.
European Journal of Cancer (Oxford, England : 1990)|October 25, 2011
The association of pre-treatment neutrophil to lymphocyte ratio with response rate, progression free survival and overall survival of patients treated with sunitinib for metastatic renal cell carcinomaDaniel Keizman, Maya Ish-Shalom, Peng Huang, et al.
Journal of Public Health Research|September 21, 2021
COVID-19 and the excess of mortality in Italy from January to April 2020: what are the risks for oldest old?Eraldo Francesco Nicotra, Roberto Pili, Luca Gaviano, et al.
Geriatrics (Basel, Switzerland)|September 23, 2024
Reconsidering "Aging Well" According to Multiple Definitions: A Multidimensional Approach to Clinical Psychology of AgingLuca Gaviano, Roberto Pili, Andrea Domenico Petretto, et al.
Geriatrics (Basel, Switzerland)|September 23, 2024
Definitions of Ageing According to the Perspective of the Psychology of Ageing: A Scoping ReviewLuca Gaviano, Roberto Pili, Andrea Domenico Petretto, et al.
Journal of Medicinal Chemistry|April 28, 2006
Identification of type 1 inosine monophosphate dehydrogenase as an antiangiogenic drug targetCurtis R Chong, David Z Qian, Fan Pan, et al.
Cancer Research|September 18, 2004
The histone deacetylase inhibitor NVP-LAQ824 inhibits angiogenesis and has a greater antitumor effect in combination with the vascular endothelial growth factor receptor tyrosine kinase inhibitor PTK787/ZK222584David Z Qian, Xiaofei Wang, Sushant K Kachhap, et al.
Pageof 23